folder

Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.

Authors

  • V. Wais
  • L. Kündgen
  • S.R. Bohl
  • S. von Harsdorf
  • R.F. Schlenk
  • K. Döhner
  • V. Teleanu
  • L. Bullinger
  • T.M. Nguyen
  • K. Drognitz
  • J.C. Moulin
  • M. Binnenhei
  • M. Bentz
  • H. Döhner
  • D. Bunjes
  • F. Kuchenbauer
  • M. Ringhoffer

Journal

  • Bone marrow transplantation

Citation

  • Bone Marrow Transplant 53 (1): 94-96

DOI

doi:10.1038/bmt.2017.211